AFX.DE Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 geg. 2024 @ 18:35):

Stats
Šios dienos apimtis	412 286
Vidutinė apimtis	137 574
Rinkos kapitalizacija	7.57B
EPS	€0 ( 2024-05-07 )
Last Dividend	€1.100 ( 2023-03-23 )
Next Dividend	€0 ( N/A )
P/E	28.89
ATR14	€0.128 (0.15%)

Tūris Koreliacija

Ilgas: -0.02 (neutral)

Trumpas: -0.70 (moderate negative)

Signal:(44.716) Neutral

Carl Zeiss Meditec AG Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Carl Zeiss Meditec AG Koreliacija - Valiuta/Žaliavos

-0.13
( neutral )

-0.19
( neutral )

0.00
( neutral )

-0.40
( neutral )

0.13
( neutral )

0.62
( weak )

Carl Zeiss Meditec AG Finansinės ataskaitos

Annual	2023
Pajamos:	€2.09B
Bruto pelnas:	€1.21B (57.71 %)
EPS:	€3.25

FY	2023
Pajamos:	€2.09B
Bruto pelnas:	€1.21B (57.71 %)
EPS:	€3.25

FY	2022
Pajamos:	€1.90B
Bruto pelnas:	€1.13B (59.26 %)
EPS:	€3.29

FY	2021
Pajamos:	€1.65B
Bruto pelnas:	€967.21M (58.73 %)
EPS:	€2.64

Financial Reports:

No articles found.

Carl Zeiss Meditec AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€1.100 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Carl Zeiss Meditec AG Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.45 - good (94.53%) | Divividend Growth Potential Score: 6.71 - Stable (34.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.117	2006-03-13
Last Dividend	€1.100	2023-03-23
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	€8.36	--
Avg. Dividend % Per Year	0.00%	--
Score	3.11	--
Div. Sustainability Score	9.45
Div.Growth Potential Score	6.71
Div. Directional Score	8.08	--

Next Divdend (Est)
(2024-12-17)

€0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.11

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
TNE5.DE	Ex Dividend Junior	2023-12-12	Semi-Annually	0.00%
185.DE	Ex Dividend Junior	2023-08-07	Quarterly	0.00%
HP3A.DE	Ex Dividend Knight	2023-06-21	Annually	0.00%
AIY.DE	Ex Dividend Junior	2023-08-01	Sporadic	0.00%
M4I.DE	Ex Dividend Knight	2023-10-05	Quarterly	0.00%
CMC.DE	Ex Dividend Knight	2023-10-05	Quarterly	0.00%
PFE.DE	Ex Dividend Junior	2023-07-27	Quarterly	0.00%
ETG.DE	Ex Dividend Junior	2023-07-04	Annually	0.00%
SWTF.F	Ex Dividend Junior	2023-08-23	Semi-Annually	0.00%
HAW.DE	Ex Dividend Junior	2023-06-13	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.103	1.500	7.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0895	1.200	7.02	8.42	[0 - 0.3]
returnOnEquityTTM	0.124	1.500	9.73	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.51	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	0.761	0.800	-0.232	-0.185	[0.8 - 2.5]
cashRatioTTM	0.0302	1.500	-0.943	-1.415	[0.2 - 2]
debtRatioTTM	0.0486	-1.500	9.19	-10.00	[0 - 0.6]
interestCoverageTTM	22.96	1.000	2.61	2.61	[3 - 30]
operatingCashFlowPerShareTTM	2.95	2.00	9.02	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.361	2.00	9.32	10.00	[0 - 20]
debtEquityRatioTTM	0.0678	-1.500	9.73	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.645	1.000	2.58	2.58	[0.2 - 0.8]
operatingProfitMarginTTM	0.166	1.000	8.67	8.67	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.854	1.000	0.811	0.811	[0.2 - 2]
assetTurnoverTTM	0.869	0.800	7.54	6.03	[0.5 - 2]
Total Score				9.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	28.96	1.000	7.18	0	[1 - 100]
returnOnEquityTTM	0.124	2.50	9.83	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.361	2.00	9.55	10.00	[0 - 30]
dividendYielPercentageTTM	1.299	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.95	2.00	9.02	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.88	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.104	1.000	9.91	0	[0.1 - 0.5]
Total Score				6.71

Carl Zeiss Meditec AG Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.